Increased FABP3 levels were found in the CSF of patients with different neurological disorders, including Creutzfeldt-Jakob disease (CJD), AD in both its prodromal and dementia phases, and vascular dementia (VAD) [25–31]. This evidence concerns the gene FABP3 and dementia.